Aindo

Aindo provides a synthetic data platform designed to transform private healthcare information into clinical evidence while maintaining GDPR and AI Act compliance. The company enables researchers, pharmaceutical firms, and public health institutions to generate high-quality synthetic cohorts for real-world evidence, external control arms, and clinical intelligence. Its technology facilitates faster observational studies and medical reasoning by providing analysis-ready data that preserves the statistical characteristics of real patient populations without exposing sensitive personal identifiers.